Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Epiction of the Genomic and Genetic Landscape Identifies CCL5 as a Protective Factor in Colorectal Neuroendocrine Carcinoma

NCT05714722 is registered in ClinicalTrials.gov with Zhejiang University as lead sponsor.

NCT NCT05714722
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05714722 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Epiction of the Genomic and Genetic Landscape Identifies CCL5 as a Protective Factor in Colorectal Neuroendocrine Carcinoma
Lead sponsor
Zhejiang University
Phase
Observational
Overall status
Completed
Start date
January 1, 2011
Completion date
January 1, 2021
Enrollment
60 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

colorectal neuroendocrine carcinomas (crnec); genomic landscape; genetic landscape; prognosis; ccl5; pax5